Alpha Tau Medical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Alpha Tau Medical Ltd
Access all reports
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. The company specializes in the research, development, and commercialization of its proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This innovative therapy is designed for the treatment of solid tumors, with the ability to deliver highly potent and localized alpha radiation, minimizing damage to surrounding healthy tissues. Alpha Tau is focused on addressing unmet needs in various cancer types, including skin, oral, pancreatic, and prostate cancers, among others. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
DRTS
Country
🇺🇸 United States